
Speaking
I speak about what I've spent twenty years learning: how capital decisions, vendor dynamics, and technology promises play out inside real oncology programs. No hype. Just what I've seen work and what I've seen fail.
Key Topics
Protecting Program Margin in a Challenging Reimbursement Environment
Delivered at the AMAC Spring Symposium 2026. How purchasing frameworks, service contract structures, and vendor negotiation dynamics affect the bottom line for radiation oncology programs.
AI Snake Oil vs. Clinical Reality
Where AI delivers real ROI in oncology and where it burns capital. A vendor-side perspective on what's being sold versus what actually works in the workflow.
Global Commercialization Strategy
What US companies get wrong entering EMEA and LATAM markets. Cultural integration, distribution management, and building international teams that perform.
SROA Annual Meeting 2026 keynote, Boston, 52 minutes.
Formats and audience
Keynote or breakout, 45 to 60 minutes, with questions. Panel and pre-conference course formats on request. Built for radiation oncology administrators, cancer center executives, physician leaders and the finance people who sit across from them. Recordings are welcome.
Engagements
-
AMAC Winter Seminar, December 3 to 4, 2026: Both Sides of the Table, with Heather Turner (upcoming)
-
SROA Annual Meeting 2026, Boston, September 29, 2026. "From Hype to Value: A Practical Framework for Evaluating AI Investments in Radiation Oncology." Sole speaker, 60 minutes.
-
SROA New Administrator Pre-Conference Course, September 26, 2026. "Both Sides of the Table." Business and Leadership session, with Heather Turner.
-
AMAC Summer Seminar, July 2026. "Protecting Program Margin, Part Two: Putting the Framework to Work."
-
AMAC Spring Symposium, April 2026. "Protecting Program Margin."
-
SROA Annual Meeting 2025. "Strategic Contract Negotiations in Radiation Oncology: A Peek at the Vendor Side."
-
The Medsolve Dynamics Podcast, ongoing.
Bio for organizers
Yoel Bakas is the founder of Medsolve Dynamics, an oncology consulting firm that works with cancer programs on capital, service contracts, margin and AI. Before that he spent twenty years on the vendor side: he ran the oncology national accounts at GE HealthCare, where he built GEMINI-RT, the GE and Mayo Clinic AI collaboration; global strategic operations, software and customer success at ViewRay; global sales at Mevion; and, for thirteen years, some of the biggest national accounts at Varian. He holds a computer science degree and an MBA in AI, and is Harvard Medical AI certified.